Corbus announces common stock and warrants offering, no amount given

Corbus Pharmaceuticals (CRBP) Holdings announced that it plans to offer and sell shares of its common stock or, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock in an underwritten registered public offering. All of the securities in the offering are to be sold by Corbus. Corbus intends to use the net proceeds of the proposed underwritten offering to fund the clinical development of its pipeline and for working capital and other general corporate purposes. Jefferies and Piper Sandler & Co. are acting as joint book-running managers for the offering.